文献速递糖尿病

1型糖尿病缓慢进展者随时间推移胰岛自身抗体丢失、胰岛抗原特异性CD8+ T细胞少并呈现独特的CD95hi B细胞表型

Slow progressors to type 1 diabetes lose islet autoantibodies over time, have few islet antigen-specific CD8+ T cells and exhibit a distinct CD95hi B cell phenotype.
PubMed 文献 · Diabetologia · 2020-03-10

本研究比较了1型糖尿病缓慢进展者、新诊断或长期1型糖尿病患者及健康个体的外周血免疫指标。发现缓慢进展者随时间推移胰岛自身抗体丢失,多种B细胞亚群CD95表达升高,且对胰岛素原的自身反应性B细胞频率更高,而胰岛抗原特异性CD8+ T细胞反应大多缺失。作者认为这些表型变化需在更大队列中进一步研究以确定其功能意义。

要点

  • 1型糖尿病缓慢进展者随时间推移胰岛自身抗体丢失。
  • 缓慢进展者多种B细胞亚群CD95表达高于健康供者,尤其在多克隆刺激后。
  • 缓慢进展者胰岛素原自身反应性B细胞频率高于健康供者,而胰岛抗原特异性CD8+ T细胞反应大多缺失。

核心结论

  • 本研究发现1型糖尿病缓慢进展与胰岛自身抗体丢失及独特的B细胞表型相关,符合通过CD95增强对外周自身反应性的凋亡调控。
  • 作者认为这些表型变化需在更大队列中进一步研究以确定其功能意义。

研究设计与样本

  • 研究比较了1型糖尿病缓慢进展者、新诊断或长期1型糖尿病患者及健康个体外周血样本的免疫学变量。
  • 采用多色流式细胞术表征B细胞和T细胞表型,用酶联免疫斑点(ELISpot)法量化胰岛自身抗原特异性B细胞,用肽-HLA I类四聚体量化胰岛自身抗原特异性CD8+ T细胞,用放射免疫分析检测胰岛自身抗体,用ELISA检测血清趋化因子、细胞因子和可溶性受体。

主要发现

  • 缓慢进展者随时间推移胰岛自身抗体丢失。
  • 与健康供者相应B细胞亚群相比,缓慢进展者多种B细胞亚群CD95表达更高(p < 0.05),尤其在多克隆刺激后。
  • 缓慢进展者与健康供者的CD4+和CD8+ T细胞表型特征相似。
  • 与健康供者相比,缓慢进展者中央记忆表型(CD27int、CD127+、CD95int)CD4+ T细胞频率更低(占总CD4+ T细胞平均百分比:缓慢进展者3.00% vs 健康供者4.67%,p < 0.05)。
  • ELISpot assay中,与健康供者相比,缓慢进展者对胰岛素原的自身反应性B细胞反应频率更高(中位斑点数量:健康供者0 vs 缓慢进展者24.34,p < 0.05)。

局限性

  • 作者指出这些表型变化需在更大队列中进一步研究以确定其功能意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The aim of this study was to characterise islet autoantibody profiles and immune cell phenotypes in slow progressors to type 1 diabetes. METHODS: Immunological variables were compared across peripheral blood samples obtained from slow progressors to type 1 diabetes, individuals with newly diagnosed or long-standing type 1 diabetes, and healthy individuals. Polychromatic flow cytometry was used to characterise the phenotypic attributes of B and T cells. Islet autoantigen-specific B cells were quantified using an enzyme-linked immunospot (ELISpot) assay and islet autoantigen-specific CD8+ T cells were quantified using peptide-HLA class I tetramers. Radioimmunoassays were used to detect islet autoantibodies. Sera were assayed for various chemokines, cytokines and soluble receptors via ELISAs. RESULTS: Islet autoantibodies were lost over time in slow progressors. Various B cell subsets expressed higher levels of CD95 in slow progressors, especially after polyclonal stimulation, compared with the corresponding B cell subsets in healthy donors (p < 0.05). The phenotypic characteristics of CD4+ and CD8+ T cells were similar in slow progressors and healthy donors. Lower frequencies of CD4+ T cells with a central memory phenotype (CD27int, CD127+, CD95int) were observed in slow progressors compared with healthy donors (mean percentage of total CD4+ T cells was 3.00% in slow progressors vs 4.67% in healthy donors, p < 0.05). Autoreactive B cell responses to proinsulin were detected at higher frequencies in slow progressors compared with healthy donors (median no. of spots was 0 in healthy donors vs 24.34 in slow progressors, p < 0.05) in an ELISpot assay. Islet autoantigen-specific CD8+ T cell responses were largely absent in slow progressors and healthy donors. Serum levels of DcR3, the decoy receptor for CD95L, were elevated in slow progressors compared with healthy donors (median was 1087 pg/ml in slow progressors vs 651 pg/ml in healthy donors, p = 0.06). CONCLUSIONS/INTERPRETATION: In this study, we found that slow progression to type 1 diabetes was associated with a loss of islet autoantibodies and a distinct B cell phenotype, consistent with enhanced apoptotic regulation of peripheral autoreactivity via CD95. These phenotypic changes warrant further studies in larger cohorts to determine their functional implications.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Hanna SJ, Powell WE, Long AE, et al. Slow progressors to type 1 diabetes lose islet autoantibodies over time, have few islet antigen-specific CD8+ T cells and exhibit a distinct CD95hi B cell phenotype. Diabetologia. 2020. PMID: 32157332. doi:10.1007/s00125-020-05114-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。